Preliminary screening for antibacterial and antimycobacterial activity of actinomycetes from less explored ecosystems

World Journal of Microbiology and Biotechnology

Volumn 26, Issue 3, 2010, Pages 561-566

  Radhakrishnan, Manikkam ^a   Suganya, S ^a   Balagurunathan, Ramasamy ^b   Kumar, Vanaja ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b PERIYAR UNIVERSITY   (India)

Author keywords

Actinomycetes; Antimycobacterial activity; Less explored ecosystems; LRP assay; Streptomyces

Indexed keywords

ACTINOMYCETES; ALKALINE SOILS; ANTI-BACTERIAL ACTIVITY; ANTI-MYCOBACTERIAL; ANTIMYCOBACTERIAL ACTIVITY; BIOACTIVE COMPOUNDS; CLINICAL ISOLATES; CRUDE EXTRACT; CULTURE FILTRATE; CULTURE SUPERNATANT; DIFFUSION METHOD; ETHYL ACETATES; GRAM POSITIVE; GRAM-NEGATIVE BACTERIA; HUMAN PATHOGENS; M. TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; SHAKE FLASKS; SOYBEAN MEAL; STANDARD STRAIN;

BACTERIA; ESTERS; METHANOL; SOLVENT EXTRACTION; STRAIN;

ECOSYSTEMS;

ACTINOBACTERIA; ACTINOBACTERIA (CLASS); AZADIRACHTA INDICA; GLYCINE MAX; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; POSIBACTERIA; STREPTOMYCES;

EID: 77950459774     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-009-0198-9     Document Type: Article

References (15)

1. Augustine SK, Bhavsar SP, Kapadnis BP (2005) Production of a growth dependent metabolite active against dermatophytes by Streptomyces rochei AK 39. Indian J Med Res 121: 164-170.
2. Berdy J (2005) Bioactive microbial metabolites. J Antibiot (Tokyo) 58: 1-26.
3. Busti E, Monciardini P, Cavaletti L, Bamonte R, Lazzarini A, Sosio M, Donadio S (2006) Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiol 152: 675-683.
4. Casenghi M, Cole ST, Nathan CF (2007) New approaches to filling the gap in tuberculosis drug discovery. PLoS Med 4: e293.
5. De Souza MV (2006) Promising drugs against tuberculosis. Recent Pat Antiinfect Drug Discov 1: 33-44.
6. El Sayed KA, Bartyzel P, Shen X, Perry TL, Zjawiony JK, Hamann MK (2000) Marine natural products as antituberculosis agents. Tetrahedron 56: 949-953.
7. Franco MM, Countinho LEL (1991) Detection of novel secondary metabolites. Crit Rev Microbiol 11: 193-276.
8. Kobarfard F (2004) Tuberculosis and traditional medicine: fighting the oldest infectious disease using the oldest source of medicine. Iranian J Phar Res 2: 71-72.
9. Lam KS (2006) Discovery of novel metabolites from marine actinomycetes. Curr Opin Microbiol 9: 245-251.
10. Nonomura H (1974) Key for classification and identification of 458 species of the streptomycetes included in ISP. J Ferment Technol 52(2): 78-92.
11. Radhakrishnan M, Balaji S, Balagurunathan R (2007) Thermotolerant actinomycetes from the Himalayan mountain-antagonistic potential, characterization and identification of selected strains. Malays Appl Biol 36(1): 59-65.
12. Riska PF, Su Y, Bardarov S, Freundlich L, Sarkis G, Hatfull G, Carriere C, Kumar V, Chan J, Jacobs WR Jr (1999) Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 37: 1144-1149.
13. Saha M, Jaisankar P, Das J, Sarkar KK, Roy S, Bersa SB, Vedasiromani JR, Ghosh D, Sana B, Mukherjee J (2006) Production and purification of bioactive substance inhibiting multiple drug resistant bacteria and human leukemia cells from a salt-tolerant marine Actinobacterium sp. isolated from the Bay of Bengal. Biotechnol Lett 28: 1083-1088.
14. Shirling EB, Gottileb D (1966) Methods for characterization of Streptomyces species. Int J Syst Bacteriol 16: 313-340.
15. Sivakumar PM, Seenivasan SP, Kumar V, Doble M (2007) Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg Med Chem Lett 17: 1695-1700.